Nate Hansen, Director of Sales, Neil Travis, Director of Operations, and Matt Dambeck, CEO
The 2025 Mitral Conclave in New York City brought together a highly specialized group of cardiac surgeons for focused, in-depth discussion around mitral valve repair. Designed as a forum for technical exchange and surgeon-led dialogue, the meeting provided an ideal setting to engage the mitral repair community on evolving approaches, challenges, and long-term considerations in repair strategy.
For Genesee BioMedical, Mitral Conclave marked an important moment in that ongoing conversation.
Introducing the TransForm™ McCarthy Mitral Annuloplasty Ring
During the meeting, Genesee BioMedical showcased its latest annuloplasty solution, the TransForm™ McCarthy Mitral Annuloplasty Ring, presenting it to the cardiac surgery community as the only ring designed for lifetime management of mitral repair patients.
TransForm™ is a complete mitral annuloplasty ring designed by Patrick McCarthy, MD, in collaboration with Northwestern University, and engineered for use in mitral valve repair across all etiologies and surgical approaches, including minimally invasive, robotic, and open surgery.
Discussions at Mitral Conclave centered on the ring’s surgeon-led design philosophy and its role in supporting mitral repair today while considering long-term patient management. Surgeons engaged in dialogue around annuloplasty design, procedural flexibility, and how thoughtful engineering can support consistency across varying anatomies and surgical techniques.
Patrick McCarthy, MD of Northwestern Medicine and Daniel O’Hair, M.D. from Lee Health
A Design Built for Surgical Familiarity and Flexibility
The TransForm™ McCarthy Mitral Annuloplasty Ring features a familiar saddle-shaped geometry, intended to minimize the learning curve for surgeons, along with a silicone core and targeted stiffeners that allow for controlled stretch and elastic support.
Its flexible design enables insertion through small incisions, supporting use across minimally invasive and robotic approaches. TransForm™ is also engineered to transform from its native D-shape to a circular geometry, supporting annular behavior relevant to future intervention considerations.
At Mitral Conclave, these design elements served as a foundation for thoughtful discussion that connected engineering intent with real-world surgical experience.
Building Momentum Toward STS 2026
Following a successful debut at Mitral Conclave, the conversation continues. Genesee BioMedical will next bring the TransForm™ McCarthy Mitral Annuloplasty Ring to the Society of Thoracic Surgeons Annual Meeting (STS) Annual Meeting in January 2026.
The Genesee BioMedical team will be on site, joined by attending surgeons, to continue discussions around TransForm™ and its role in modern mitral repair. The team is excited to continue building on the momentum generated in New York City and carrying the dialogue forward into the new year.
Looking Ahead
Mitral Conclave reinforced the value of focused, surgeon-driven exchange in advancing mitral repair. As conversations evolve from one meeting to the next, Genesee BioMedical remains committed to engaging closely with the cardiac surgery community and supporting thoughtful innovation grounded in surgical practice.